智通财经网·2025-08-08 12:00Group 1 - Liou Co., Ltd. plans to use up to 3 billion yuan of its own funds for securities investment, including new stock placements, stock and bond investments, and entrusted financial management [1] - Anke Biotech's subsidiary has developed PA3-17 injection, which has been included in the list of proposed breakthrough therapeutic products by the National Medical Products Administration, showing an objective response rate of 84.6% in clinical trials [2] - Shuangyi Technology reported a net profit of 99.87 million yuan for the first half of 2025, a year-on-year increase of 324.5%, driven by increased domestic wind power installations and overseas demand for large MW wind turbines [3] Group 2 - Chuangyuan Co., Ltd. stated that the impact of its new products launched in collaboration with domestic animation IPs on revenue and profit is limited in the short term [4] - Puyuan Precision plans to issue H-shares and list on the Hong Kong Stock Exchange to enhance its competitiveness and international brand image [5] - Tianyang Technology acquired a 51% stake in Moshuzhijing for 30.6 million yuan, aiming to enhance R&D and expand into international markets [6] Group 3 - Wanxing Technology also plans to issue H-shares and list on the Hong Kong Stock Exchange to further its globalization strategy [8] - Tianfu Communication's shareholder plans to transfer 1.27% of shares due to personal funding needs, with a transfer price based on the average stock price [9] - Hongtian Co., Ltd. reported that orders for its mask and glass substrate equipment have not yet generated revenue or profit [10] Group 4 - Jihua Group is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations, clarifying that its main business does not involve brain-computer interface technology [11] - Innovation Medical reported a net loss of 11.36 million yuan for the first half of 2025, an improvement from the previous year's loss of 16.03 million yuan [12] - Shuoshi Biotech's net profit decreased by 86.35% year-on-year, with a proposed cash dividend of 34 yuan per 10 shares [13] Group 5 - Furi Electronics achieved a net profit of 22.08 million yuan in the first half of 2025, recovering from a loss of 93.51 million yuan in the same period last year, driven by improved gross margins in its LED display business [14] - Shiyun Circuit's shareholder plans to reduce its stake by up to 3% [15] - Huaxia Happiness's shareholders plan to reduce their holdings by up to 3% [16] - Henggong Precision's shareholder intends to reduce its stake by up to 3% [17]